tiprankstipranks
Trending News
More News >
Zuiko Corporation (JP:6279)
:6279
Japanese Market

Zuiko Corporation (6279) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Zuiko Corporation

(6279)

Rating:45Neutral
Price Target:
¥1,027.00
▲(5.77%Upside)
Zuiko Corporation's overall stock score of 45 reflects significant challenges in financial performance, particularly in revenue and profitability. The technical analysis shows bearish momentum, while the valuation is impacted by unprofitability and a low dividend yield. The strong balance sheet provides some stability, but improvements in operational efficiency are needed for a positive outlook.

Zuiko Corporation (6279) vs. iShares MSCI Japan ETF (EWJ)

Zuiko Corporation Business Overview & Revenue Model

Company DescriptionZuiko Corporation (6279) is a Japanese company primarily engaged in the manufacturing and sale of machinery and equipment. The company specializes in producing advanced production systems, particularly for the hygiene and medical sectors. Zuiko is known for its innovative technology in the production of disposable diapers, sanitary napkins, and face masks, catering to both domestic and international markets.
How the Company Makes MoneyZuiko Corporation generates revenue through the sale of its high-tech machinery and equipment designed for the production of hygienic and medical products. The company's key revenue streams include the manufacture and sale of production lines for disposable hygiene products like diapers and sanitary napkins. Additionally, Zuiko provides maintenance services and technological support for its equipment, offering comprehensive solutions that enhance customer loyalty and recurring income. Significant partnerships with leading global consumer goods companies also contribute to its earnings, as these collaborations facilitate the adoption of Zuiko's machinery in large-scale production settings.

Zuiko Corporation Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
25.71B21.74B26.51B23.58B23.09B27.61B
Gross Profit
4.60B4.60B5.75B5.34B4.45B4.86B
EBIT
82.50M1.03B1.80B2.15B1.89B2.43B
EBITDA
2.85B2.85B4.33B2.97B2.55B2.82B
Net Income Common Stockholders
408.89M1.38B2.67B1.74B1.62B1.76B
Balance SheetCash, Cash Equivalents and Short-Term Investments
15.58B14.48B14.03B13.85B10.53B12.26B
Total Assets
50.68B49.27B49.64B50.21B42.33B34.94B
Total Debt
7.60B7.53B7.77B8.02B5.03B80.92M
Net Debt
-7.98B-6.95B-6.26B-5.84B-5.50B-12.18B
Total Liabilities
17.16B14.52B16.55B20.16B14.84B8.83B
Stockholders Equity
33.51B34.75B33.09B30.06B27.48B26.11B
Cash FlowFree Cash Flow
628.62M-676.82M-334.50M-89.00M-6.38B2.93B
Operating Cash Flow
628.62M-322.68M388.05M2.25B1.82B3.15B
Investing Cash Flow
0.001.12B-1.37B-1.42B-10.00B-312.54M
Financing Cash Flow
0.00-1.06B-822.86M2.48B4.66B-420.49M

Zuiko Corporation Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price971.00
Price Trends
50DMA
1032.22
Negative
100DMA
1139.82
Negative
200DMA
1194.12
Negative
Market Momentum
MACD
-18.52
Negative
RSI
50.51
Neutral
STOCH
90.64
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6279, the sentiment is Neutral. The current price of 971 is below the 20-day moving average (MA) of 974.50, below the 50-day MA of 1032.22, and below the 200-day MA of 1194.12, indicating a neutral trend. The MACD of -18.52 indicates Negative momentum. The RSI at 50.51 is Neutral, neither overbought nor oversold. The STOCH value of 90.64 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6279.

Zuiko Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥24.63B8.59
4.66%10.00%2.09%
78
Outperform
¥28.37B12.08
4.47%4.40%18.83%
77
Outperform
¥27.15B7.07
4.30%7.43%18.47%
72
Outperform
¥26.26B12.03
4.08%-12.88%-69.11%
71
Outperform
¥24.00B16.41
1.83%7.26%28.17%
66
Neutral
$4.49B12.345.40%248.65%4.13%-12.33%
45
Neutral
¥25.52B
1.01%-8.22%-157.11%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6279
Zuiko Corporation
986.00
-62.63
-5.97%
JP:6125
Okamoto Machine Tool Works,Ltd.
3,930.00
-663.25
-14.44%
JP:6137
Koike Sanso Kogyo Co., Ltd.
1,193.00
92.15
8.37%
JP:6144
Seibu Electric & Machinery Co., Ltd.
1,893.00
30.88
1.66%
JP:6405
Suzumo Machinery Co., Ltd.
1,856.00
427.46
29.92%
JP:7525
RIX Corporation
3,015.00
147.89
5.16%

Zuiko Corporation Corporate Events

Zuiko Corporation Announces Treasury Share Disposal for Director Compensation
May 16, 2025

Zuiko Corporation announced the disposal of 15,200 treasury shares as part of a restricted stock compensation plan aimed at incentivizing directors and aligning their interests with shareholders. This move is expected to enhance corporate value and ensure sustainable growth, with the shares being allocated to directors who will contribute their monetary compensation claims as part of the plan.

Zuiko Corporation Announces Change in Certified Public Accountant
Apr 10, 2025

Zuiko Corporation has announced a change in its certified public accountant, transitioning from Ernst & Young ShinNihon LLC to Grant Thornton Taiyo LLC, effective May 16, 2025. This decision was driven by the expiration of the current auditor’s term and a comprehensive assessment of audit fees and firm capabilities, aiming to bring new perspectives to their audit processes.

Zuiko Corporation Unveils Ambitious Medium-Term Business Plan
Apr 4, 2025

Zuiko Corporation has announced its 4th Medium-Term Business Plan for FY2025 to FY2027, emphasizing ‘Speed & Challenge’ as its guiding principles. The plan aims to enhance the company’s market position by focusing on creativity, technological advancement, and pioneering efforts to meet and exceed customer expectations in the health care industry.

Zuiko Corporation Announces Dividend of Surplus for Fiscal Year 2025
Apr 4, 2025

Zuiko Corporation announced a resolution to pay dividends of surplus with a record date of February 20, 2025, as approved by its Board of Directors. Despite a shortfall in profit attributable to owners of the parent, the company aims to maintain a dividend payout ratio of 30%, balancing internal reserves and financial soundness, with a total annual dividend per share set at ¥10.00.

Zuiko Corporation Reports Financial Discrepancies for Fiscal Year 2025
Apr 4, 2025

Zuiko Corporation announced a discrepancy between its forecasted and actual financial results for the fiscal year ending February 20, 2025. The company’s net sales were close to expectations, but higher-than-anticipated project costs and inventory write-downs at an overseas subsidiary led to significant shortfalls in operating and ordinary profits, as well as profit attributable to owners.

Zuiko Corporation Faces Financial Challenges but Anticipates Recovery
Apr 4, 2025

Zuiko Corporation reported a challenging fiscal year ending February 20, 2025, with a noticeable decline in net sales and profits compared to the previous year. Despite the downturn, the company anticipates a recovery in the next fiscal year, forecasting an increase in net sales and a return to profitability, which could positively impact its market position and stakeholders.

Zuiko Corporation Announces Board of Directors Candidates
Mar 25, 2025

Zuiko Corporation has announced the election of candidates for its Board of Directors, which will be proposed at the upcoming 62nd Ordinary General Meeting of Shareholders. The company plans to reappoint Toyoshi Umebayashi and Yi Xu as Directors, while introducing Fumihiko Okuno as a new Director. Additionally, Jun Sakamoto is nominated as a new Outside Director on the Audit & Supervisory Committee. This reshuffling of the board is expected to bring fresh perspectives and strengthen the company’s governance structure.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.